368 related articles for article (PubMed ID: 8433635)
21. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.
Kuan RK; Janssen R; Heyward W; Bennett S; Nordyke R
Vaccine; 2013 Aug; 31(37):4024-32. PubMed ID: 23707166
[TBL] [Abstract][Full Text] [Related]
22. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
[TBL] [Abstract][Full Text] [Related]
23. The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis.
Yin J; Ji Z; Liang P; Wu Q; Cui F; Wang F; Liang X; Zhuang G
Vaccine; 2015 Jul; 33(31):3731-8. PubMed ID: 26057138
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China.
Jia Y; Li L; Cui F; Zhang D; Zhang G; Wang F; Gong X; Zheng H; Wu Z; Miao N; Sun X; Zhang L; Lv J; Yang F
Hum Vaccin Immunother; 2014; 10(10):2983-91. PubMed ID: 25483678
[TBL] [Abstract][Full Text] [Related]
25. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
26. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
Sun PP; Zhang SX; Xia Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
[No Abstract] [Full Text] [Related]
27. Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits.
Boccalini S; Taddei C; Ceccherini V; Bechini A; Levi M; Bartolozzi D; Bonanni P
Hum Vaccin Immunother; 2013 May; 9(5):1119-28. PubMed ID: 23376840
[TBL] [Abstract][Full Text] [Related]
28. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen.
Schalm SW; Mazel JA; de Gast GC; Heijtink RA; Botman MJ; Bänffer JR; Cerards LJ; Zwijnenberg J; Fetter WP; Nuijten SM
Pediatrics; 1989 Jun; 83(6):1041-8. PubMed ID: 2726331
[TBL] [Abstract][Full Text] [Related]
29. Universal Hepatitis B Antibody Screening and Vaccination in Pregnancy: A Cost-Effectiveness Analysis.
Prabhu M; Susich MK; Packer CH; Hersch AR; Riley LE; Caughey AB
Obstet Gynecol; 2022 Mar; 139(3):357-367. PubMed ID: 35115449
[TBL] [Abstract][Full Text] [Related]
30. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
[No Abstract] [Full Text] [Related]
31. Impact of hepatitis B virus infection on women and children.
Shapiro CN; Margolis HS
Infect Dis Clin North Am; 1992 Mar; 6(1):75-96. PubMed ID: 1533649
[TBL] [Abstract][Full Text] [Related]
32. Implementing universal vaccination programmes: USA.
Kane M
Vaccine; 1995; 13 Suppl 1():S75-6. PubMed ID: 7571840
[TBL] [Abstract][Full Text] [Related]
33. Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark.
Harder KM; Cowan S; Eriksen MB; Krarup HB; Christensen PB
Vaccine; 2011 Nov; 29(50):9303-7. PubMed ID: 22019756
[TBL] [Abstract][Full Text] [Related]
34. Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.
Lee D; Park SM
PLoS One; 2016; 11(11):e0165879. PubMed ID: 27802340
[TBL] [Abstract][Full Text] [Related]
35. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.
Thomas AR; Fiore AE; Corwith HL; Cieslak PR; Margolis HS
Pediatr Infect Dis J; 2004 Apr; 23(4):313-8. PubMed ID: 15071284
[TBL] [Abstract][Full Text] [Related]
37. Post-vaccination serologic testing of infants born to hepatitis B surface antigen-positive mothers is more cost-effective in Zhejiang Province, China: A Markov chain analysis.
Lu Z; Zhou Y; Yan R; Deng X; Tang X; Zhu Y; Xu X; Zheng W; He H
J Viral Hepat; 2022 Apr; 29(4):280-288. PubMed ID: 35075747
[TBL] [Abstract][Full Text] [Related]
38. Economic evaluations of hepatitis B vaccination for developing countries.
Tu HA; Woerdenbag HJ; Kane S; Riewpaiboon A; van Hulst M; Postma MJ
Expert Rev Vaccines; 2009 Jul; 8(7):907-20. PubMed ID: 19538116
[TBL] [Abstract][Full Text] [Related]
39. Economic evaluation of universal newborn hepatitis B vaccination in China.
Lu SQ; McGhee SM; Xie X; Cheng J; Fielding R
Vaccine; 2013 Apr; 31(14):1864-9. PubMed ID: 23384752
[TBL] [Abstract][Full Text] [Related]
40. Vaccination against hepatitis B virus infection in neonates.
Pongpipat D; Suvatte V; Assateerawatts A
Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
